Skip to main contentSkip to navigation
Sirius Investors
Nevro Corp.

Nevro Corp.

NVRO
NYSEHealthcare

Revenue Analysis - NVRO

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

NVRO Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Painful Diabetic Neuropathy

0.0% of total revenue

$22.5M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Painful Diabetic Neuropathy
12/31/2023$22.5M
9/30/2023$20.8M
6/30/2023$19.0M
3/31/2023$15.6M
12/31/2022$17.6M
9/30/2022$13.4M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Stable Segments
Painful Diabetic Neuropathy+8.2%

Geographic Regions

Growing Regions
UNITED STATES+117.1%
Non-US+111.9%

Earnings Reports

Want to see how NVRO's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports